See also this year's filing and all EDGAR filings for this company.
PDF Report 0001270073_2022_Intercept_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001270073, Intercept Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 502,292,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 3,377,000 |
| 3 | remainder_Assets | 21,354,000 |
| 4 | LiabilitiesCurrent | 166,817,000 |
| 5 | LiabilitiesNoncurrent | 544,168,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 1,624,138 |
| 8 | SellingGeneralAndAdministrativeExpense | 173,663,635 |
| 9 | ResearchAndDevelopmentExpense | 183,974,561 |
| 10 | remainder_Expenses | 14,415,210 |
| 11 | remainder_Revenues | 505,800,652 |
| 12 | remainder_NetIncome | -34,007,240 |
| 13 | remainder_ComprehensiveNetIncome | -997,966 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 527,023,000 |
| 1 | Liabilities | 710,985,000 |
| 2 | Expenses | 373,677,544 |
| 3 | Revenues | 505,800,652 |
| 4 | StockholdersEquity | -183,962,000 |
| 5 | NetIncome | 98,115,868 |
| 6 | ComprehensiveNetIncome | 97,616,885 |
| 7 | BaseVar | 1,076,245,701 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.490 |
| 9 | EconomicCapitalRatio | 1.38 |
Edgar->Model Mapping
Feature Distribution
Change over Time
